PYXIS ONCOLOGY INC (PYXS) Stock Cash Flow
NASDAQ:PYXS - Nasdaq - US7473241013 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -95.23M | -77.33M | -73.79M | -120.72M | -75.98M | |||
| Depreciation Amortization | 2.42M | 2.98M | 1.93M | 710.00K | 650.00K | |||
| Income Taxes - Deferred | N/A | -2.16M | N/A | N/A | N/A | |||
| Change In Working Capital | 7.51M | -9.66M | -11.66M | 4.50M | 6.68M | |||
| Interest Paid | N/A | 10.00K | N/A | N/A | N/A | |||
| Taxes Paid | N/A | 164.00K | 48.00K | 20.00K | N/A | |||
| Other non cash items | 27.97M | 28.50M | 12.82M | 26.17M | 33.33M | |||
| OPERATING CASH FLOW | -59.50M | -57.67M | -70.71M | -89.34M | -35.33M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -237.00K | -6.73M | -6.40M | -540.00K | |||
| Other Investing Activity | 42.47M | 8.39M | -98.12M | 0.00 | -50.00K | |||
| INVESTING CASH FLOW | 42.47M | 8.15M | -104.85M | -6.40M | -590.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 1.86M | 59.57M | 6.24M | 180.00K | 304.04M | |||
| Other Financing Activity | -46.00K | -240.00K | -313.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 1.81M | 59.33M | 5.93M | 180.00K | 304.04M | |||
| CHANGE IN CASH | -15.21M | 9.81M | -169.63M | -95.56M | 268.12M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -59.50M | -57.67M | -70.71M | -89.34M | -35.33M | |||
| Capital Expenditure | N/A | -237.00K | -6.73M | -6.40M | -540.00K | |||
| FREE CASH FLOW | -59.50M | -57.91M | -77.44M | -95.74M | -35.87M | |||
All data in USD